Cargando…
Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib
Aicardi-Goutières syndrome (AGS) is a rare hereditary early-onset encephalopathy. The syndrome was first described in 1984, and is characterised by upregulation of the type I interferon (IFN) pathway, which is involved in the host immune response against viral infections, including SARS-CoV-2. Whils...
Autores principales: | Pararajasingam, Abirami, Bradley, Rachel E., Evans, Jennifer, Lowe, Ashima, Goodwin, Richard, Jolles, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085217/ https://www.ncbi.nlm.nih.gov/pubmed/35547545 http://dx.doi.org/10.3389/fped.2022.837568 |
Ejemplares similares
-
Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation
por: Cattalini, Marco, et al.
Publicado: (2021) -
Case Report: Aicardi-Goutières Syndrome Caused by Novel TREX1 Variants
por: Wu, De, et al.
Publicado: (2021) -
Aicardi–Goutières syndrome with SAMHD1 deficiency can be diagnosed by unscheduled DNA synthesis test
por: Senju, Chikako, et al.
Publicado: (2022) -
MRI Features Predictive of Aicardi-Goutieres Syndrome
por: Millichap, J. Gordon
Publicado: (2015) -
Aicardi–Goutières Syndrome: Brief Case Report
por: Moscote-Salazar, Luis Rafael, et al.
Publicado: (2018)